Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
38.75
-0.05 (-0.13%)
At close: Jul 8, 2026, 4:00 PM EDT
38.80
+0.05 (0.13%)
After-hours: Jul 8, 2026, 4:10 PM EDT

Nanobiotix Revenue

In the year 2025, Nanobiotix had annual revenue of 32.59M EUR. Nanobiotix had revenue of 5.96M in the half year ending December 31, 2025, a decrease of -81.91%.

Revenue (ttm)
32.59M EUR
Revenue Growth
n/a
P/S Ratio
50.49
Revenue / Employee
325,930 EUR
Employees
100
Market Cap
1.93B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202532.59M39.78M-
Dec 31, 2024-7.19M-43.40M-
Dec 31, 202336.21M31.43M658.12%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M135.00K5.37%
Dec 31, 20202.51M-29.00K-1.14%
Dec 31, 20192.54M-938.00K-26.96%
Dec 31, 20183.48M-242.53K-6.52%
Dec 31, 20173.72M-1.70M-31.36%
Dec 31, 20165.42M1.41M35.03%
Dec 31, 20154.02M1.24M44.91%
Dec 31, 20142.77M2.59M1,398.23%
Dec 31, 2013184.94K-785.67K-80.95%
Dec 31, 2012970.61K-389.70K-28.65%
Dec 31, 20111.36M225.46K19.87%
Dec 31, 20101.13M-1.63M-59.00%
Dec 31, 20092.77M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Iovance Biotherapeutics285.61M
AnaptysBio232.39M
Nuvation Bio143.05M
Zymeworks81.26M
Precigen31.60M
AtaiBeckley3.49M
Absci1.84M
Revenue Rankings